| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +43.8K | 100% | $7.60 | +$332K |
| Sells | 0 | ||||
| Net | +1 | +43.8K | 100% | +$332K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | $46.7M | Jun 10, 2024 | ||
| Andrew R. Robbins | President and CEO, Director | $6.57M | Jan 23, 2025 | ||
| Cole Pinnow | Chief Commercial Officer | $2.07M | +$332K | +19.1% | Jan 23, 2025 |
| John Edward Robinson | Chief Scientific Officer | $1.94M | Jan 23, 2025 | ||
| John L. Green | Chief Financial Officer | $1.94M | Jan 23, 2025 | ||
| Jessica Sachs | Chief Medical Officer | $1.94M | Jan 23, 2025 | ||
| Evan Kearns | Chief Legal Officer | $1.65M | Jan 23, 2025 | ||
| Todd Shegog | Director | $321K | Jun 5, 2024 | ||
| Matthew Ros | Director | $321K | Jun 5, 2024 | ||
| Christopher W. Cain | Director | $321K | Jun 5, 2024 | ||
| Peter Evan Harwin | Director | $321K | Jun 5, 2024 | ||
| Arlene Morris | Director | $321K | Jun 5, 2024 | ||
| Karen Jean Ferrante | Director | $20K | Apr 1, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|